Manon Allaire

Durvalumab with or without bevacizumab with transarterial chemoembolisation in hepatocellular carcinoma (EMERALD-1): a multiregional, randomised, double-blind, placebo-controlled, phase 3 study

Bruno Sangro, Masatoshi Kudo, Joseph P. Erinjeri et al. · The Lancet · 2025 · 151 citations · Full text

Hepatology, Transarterial Chemoembolisation, Medicine +8

Positron emission tomography/computed tomography with 18F-fluorocholine improve tumor staging and treatment allocation in patients with hepatocellular carcinoma

Julia Chalaye, Charlotte Costentin, Alain Luciani et al. · Journal of Hepatology · 2018 · 57 citations

Positron Emission Tomography, Hepatology, Medical Imaging +11

Combination of Model for End‐Stage Liver Disease and Lactate Predicts Death in Patients Treated With Salvage Transjugular Intrahepatic Portosystemic Shunt for Refractory Variceal Bleeding

Aurélie Walter, Marika Rudler, Pol Olivas et al. · Hepatology · 2021 · 56 citations · Full text

The epidemiology of Budd–Chiari syndrome in France

Isabelle Ollivier‐Hourmand, Manon Allaire, Nathalie Goutté et al. · Digestive and Liver Disease · 2018 · 43 citations

Budd–chiari Syndrome, Pathogenesis, Clinical Epidemiology +5

Determining safe washout period for immune checkpoint inhibitors prior to liver transplantation: An international retrospective cohort study

Beat Moeckli, Charles‐Henri Wassmer, Sofia El Hajji et al. · Hepatology · 2025 · 20 citations · Full text